AAM Urges Biden-Harris Administration To Increase Biosimilar Reimbursement
As IQVIA Study Predicts $69bn-$140bn In US Healthcare Savings Due To Biosimilars
• By Akriti Seth
AAM asks policymakers to act on biosimilar reimbursement • Source: Shutterstock 
